TP53 and prostate carcinoma: Next, we performed KEGG enrichment analysis again on the 29 DEGs through DAVID and found that these genes were enriched in the p53 signaling pathway, pathways in cancer, oocyte meiosis, and prostate cancer (P<0.05).